[1] 张彩萍,季江,林麟,等.16例皮肤结核分离菌株药敏试验分析.中华皮肤科杂志,2010(42)6:371-373. [2] 中国防痨协会基础专业委员会编著.结核病诊断试验室检验规程.中国教育文化出版社,北京,1996,30-58. [3] Tracevska T, Jansone I, Broka L,et al. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol. 2002;40(10):3789-3792. [4] Shi R, Zhang J, Li C,et al. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J Clin Microbiol. 2006 ,44(12):4566-4568. [5] Migliori GB, D'Arcy Richardson M, Sotgiu G ,et al. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med. 2009 ,30(4):637-665. [6] 莫衍石,潘鹏,王立阳,等.耐多种药物寻常狼疮.临床皮肤科杂志2010,39(2):109-111. [7] Ma X, Wang H, Deng Y, et al. rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol. 2006 Sep;44(9):3409-3412. [8] 黄海荣,金奇,马玙,等.中国耐利福平结核分枝杆菌rpoB基因突变特点.中华结核和呼吸杂志,2001,24(4):231-235. [9] Guo H, Seet Q, Denkin S, et al..Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol. 2006 Nov;55(Pt 11):1527-31. |